Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Somatuline Autogel 120 mg on postoperative drainage after rectal resection for rectal carcinoma
2010-022572-32Phase 3Completed
- Sponsor
- Ghent University Hospital
- Start
- Mar 2011
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of lanreotide in rectal cancer, sponsored by Ghent University Hospital. Primary endpoint: Postoperative drain fluid production. Started Mar 2011; status: completed.
02
Drugs
lanreotide
03
Conditions
rectal cancer
Beyond the preview
Go deeper on 2010-022572-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022572-32.